CMCR

5 Surprising Facts about Medical Marijuana and Cannabinoids

UCSD Health Sciences Communications

Twenty-three states plus Washington, D.C. have enacted laws to legalize medical marijuana. But just because weed is legal doesn’t mean it’s an effective or safe therapeutic for everyone. Like any drug, marijuana has an optimal dose and potency, is indicated for only some conditions and should always be used with caution.

Here are five facts about marijuana and cannabinoids, vetted by Igor Grant, MD, chair of the Department of Psychiatry, University of California, San Diego School of Medicine and UC Center for Medicinal Cannabis Research.

See the facts here.


 

American Academy of Pediatrics, Policy Statement

Updated policy statement includes option for “compassionate use” of marijuana for children with debilitating or life-limiting diseases

In an updated policy statement and technical report, the American Academy of Pediatrics (AAP) reaffirms its opposition to legalizing marijuana, citing the potential harms to children and adolescents.

The AAP policy statement, “The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update” and an accompanying technical report will be published in the March 2015 Pediatrics (published online Jan. 26). In the policy, the Academy reaffirms its position against the legalization of marijuana, states its opposition to “medical marijuana” outside the FDA regulatory process, and presents recommendations to protect children in states that have legalized marijuana for medical or recreational purposes.

The Academy also recommends that marijuana be decriminalized, so that penalties for marijuana-related offenses are reduced to lesser criminal charges or civil penalties. Efforts to decriminalize marijuana should take place in conjunction with efforts to prevent marijuana use and promote early treatment of adolescents with marijuana use problems.

Read the full press release here.


 

Welcome to the Center for Medicinal Cannabis Research


Welcome to the University of California's Center for Medicinal Cannabis Research (CMCR). The purpose of the Center is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions. The funding of the CMCR is the result of SB 847 (Vasconcellos), passed by the State Legislature and signed into law by Governor Gray Davis. The legislation calls for a three year program overseeing objective, high quality medical research that will "enhance understanding of the efficacy and adverse effects of marijuana as a pharmacological agent," stressing that the project "should not be construed as encouraging or sanctioning the social or recreational use of marijuana" (SB 847).

 

news

 

Igor Grant Announced as New Chair of the Department of Psychiatry, University of California, San Diego

This message was sent on behalf of Dr. David Brenner, Vice Chancellor, UC San Diego Health Sciences and Dean of the School of Medicine, and Paul Viviano, Chief Executive Officer, UC San Diego Health System, to UC San Diego Health Sciences Faculty and Staff.

We are pleased to announce that Igor Grant, MD, FRCP(C), an internationally recognized neuropsychiatrist, has been named the new Chair of the Department of Psychiatry at UC San Diego School of Medicine. Dr. Grant has been at UC San Diego more than 40 years and has served as Executive Vice Chair in the department for the past 20. He will succeed Lewis Judd, MD, who is stepping down after 36 years in the position – the longest serving department chair in the history of the university.

Read more...
 
Banner
Banner
Banner

Copyright ©2010 CENTER FOR MEDICINAL CANNABIS RESEARCH | University of California, San Diego
cmcr@ucsd.edu | contact the webmaster | HNRP | HNRC | CNTN | CHARTER